Cargando…

Prognostic risk assessment model and drug sensitivity analysis of colon adenocarcinoma (COAD) based on immune-related lncRNA pairs

PURPOSE: The aim of this study was to identify and screen long non-coding RNA (lncRNA) associated with immune genes in colon cancer, construct immune-related lncRNA pairs, establish a prognostic risk assessment model for colon adenocarcinoma (COAD), and explore prognostic factors and drug sensitivit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Zezhou, Liang, Pengchen, He, Changyu, Sha, Shuang, Yang, Ziyuan, Liu, Yixin, Shi, Junfeng, Zhu, Zhenggang, Chang, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579580/ https://www.ncbi.nlm.nih.gov/pubmed/36258178 http://dx.doi.org/10.1186/s12859-022-04969-4

Ejemplares similares

The Invasion and Metastasis of Colon Adenocarcinoma (COAD) Induced by SALL4
por: Zhang, Wenjuan, et al.
Publicado: (2022)

A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma
por: Zhong, Like, et al.
Publicado: (2023)

The expression of LRRN4 was correlated with the progression and prognosis of colon adenocarcinoma (COAD) patients
por: Zhang, Yuxian, et al.
Publicado: (2021)

Establishment of a novel ferroptosis-related lncRNA pair prognostic model in colon adenocarcinoma
por: Li, Hong, et al.
Publicado: (2021)

SMYD3 promotes colon adenocarcinoma (COAD) progression by mediating cell proliferation and apoptosis
por: Yue, Fu-Ren, et al.
Publicado: (2020)

Immunoprognostic model of lung adenocarcinoma and screening of sensitive drugs
por: Liang, Pengchen, et al.
Publicado: (2022)

Integration analysis for novel lncRNA markers predicting tumor recurrence in human colon adenocarcinoma
por: Chen, Fangyao, et al.
Publicado: (2019)

A novel prognostic signature of immune-related lncRNA pairs in lung adenocarcinoma
por: Liu, Yang, et al.
Publicado: (2021)

m6A-related lncRNAs are potential biomarkers for the prognosis of COAD patients
por: Xu, Chenyang, et al.
Publicado: (2022)

Autophagy-related IFNG is a prognostic and immunochemotherapeutic biomarker of COAD patients
por: Yue, Taohua, et al.
Publicado: (2023)

Puerarin: A Potential Therapeutic for Colon Adenocarcinoma (COAD) Patients Suffering From SARS-CoV-2 Infection
por: Liang, Weizheng, et al.
Publicado: (2022)

High expression of PI4K2A predicted poor prognosis of colon adenocarcinoma (COAD) and correlated with immunity
por: Huang, Xinkun, et al.
Publicado: (2022)

Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma
por: Yin, Zhengrong, et al.
Publicado: (2022)

Development of Prognostic Indicator Based on Autophagy-Related lncRNA Analysis in Colon Adenocarcinoma
por: Zhou, Weige, et al.
Publicado: (2020)

A Deep Learning Approach for Prognostic Evaluation of Lung Adenocarcinoma Based on Cuproptosis-Related Genes
por: Liang, Pengchen, et al.
Publicado: (2023)

High expression of cuproptosis-related gene FDX1 in relation to good prognosis and immune cells infiltration in colon adenocarcinoma (COAD)
por: Wang, Lizong, et al.
Publicado: (2022)

A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures
por: Jin, Lipeng, et al.
Publicado: (2020)

Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma
por: Xiao, Junbo, et al.
Publicado: (2022)

Pyroptosis-related lncRNA pairs to estimate the molecular features and prognostic outcomes of pancreatic ductal adenocarcinoma
por: Lu, Si-Yuan, et al.
Publicado: (2022)

Identification of Immune-Related lncRNA Pairs and Construction and Validation of a New Prognostic Signature of Colon Cancer
por: Xu, Minxian, et al.
Publicado: (2022)

A 6 lncRNA-Based Risk Score System for Predicting the Recurrence of Colon Adenocarcinoma Patients
por: Yang, Haojie, et al.
Publicado: (2020)

A 7-lncRNA signature associated with the prognosis of colon adenocarcinoma
por: Fu, Xiaorui, et al.
Publicado: (2020)

Construction of an immune-related lncRNA signature pair for predicting oncologic outcomes and the sensitivity of immunosuppressor in treatment of lung adenocarcinoma
por: Zhuang, Jinman, et al.
Publicado: (2022)

LncRNA ALMS1-IT1 is a novel prognostic biomarker and correlated with immune infiltrates in colon adenocarcinoma
por: Lin, Yuning, et al.
Publicado: (2022)

Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature
por: Qi, Xiangjun, et al.
Publicado: (2021)

Prognostic value of immune-related lncRNA pairs in patients with bladder cancer
por: Gao, Zhenzhen, et al.
Publicado: (2021)

Integrated Dissection of lncRNA-miRNA-mRNA Pairs and Potential Regulatory Role of lncRNA PCAT19 in Lung Adenocarcinoma
por: Tang, Xiaomei, et al.
Publicado: (2022)

Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma
por: Xu, Miaorong, et al.
Publicado: (2022)

m6A-related lncRNA-based immune infiltration characteristic analysis and prognostic model for colonic adenocarcinoma
por: Wang, Hao-lun, et al.
Publicado: (2023)

Screening prognostic markers for hepatocellular carcinoma based on pyroptosis-related lncRNA pairs
por: Wu, Tong, et al.
Publicado: (2023)

Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma
por: Shi, Xiuhui, et al.
Publicado: (2018)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma
por: Zhu, Jinfeng, et al.
Publicado: (2022)

Construction and validation of an angiogenesis-related lncRNA prognostic model in lung adenocarcinoma
por: Gong, Quan, et al.
Publicado: (2023)

Discovered differentially expressed lncRNA AC010973.2 can act as a diagnostic and prognostic biomarker for colon adenocarcinoma
por: Liu, Xinhong, et al.
Publicado: (2020)

Constructing a prognostic immune-related lncRNA model for colon cancer
por: Li, Xinyun, et al.
Publicado: (2022)

Identification of gene signatures for COAD using feature selection and Bayesian network approaches
por: Wang, Yangyang, et al.
Publicado: (2022)

Integration analysis of long non-coding RNA (lncRNA) role in tumorigenesis of colon adenocarcinoma
por: Poursheikhani, Arash, et al.
Publicado: (2020)

Effect of Different Expression of Immune-Related lncRNA on Colon Adenocarcinoma and Its Relation to Prognosis
por: Mu, Meiwei, et al.
Publicado: (2020)

Identification and Validation of an Endoplasmic Reticulum Stress-Related lncRNA Signature for Colon Adenocarcinoma Patients
por: Chen, Xueru, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3r67phfpeqad8i3aopeammq7pb